// App-Quantinova.ai

DMX05 : A New Mechanism-Driven Framework to Define Progression in MS – a Proposal from the International Advisory Committee on Clinical Trials in MS

Researchers

Presenter

  • Jennifer Graves

Principal Investigators

  • Tanja Kuhlmann

  • Marcello Moccia

  • Timothy Coetzee

  • Jeffrey A. Cohen

  • Jorge Correale

  • Ruth Ann Marrie

  • V. Wee Yong

  • Xavier Montalban

  • Alan J Thompson

  • Daniel S. Reich

Medical Centers

  • Federico II University of Naples

  • 9Centre d’Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitario Vall d’Hebron Barcelona Spain

  • University of Manitoba,

  • University of Calgary,

  • University College London

  • National Institute of Neurological Disorders and Stroke (NINDS)

  • University Hospital Münster

  • The University of California, 
San Diego

  • Mellen Center for MS Treatment and Research, Cleveland Clinic

  • National MS Society

Locations

  • United Kingdom

  • Palestine

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved